People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

A St. Johns County man has been charged with illegally selling weight-loss drug ingredients. Adam K. Taylor is accused of ...

Research out today might provide even more of a reason for people to stay on GLP-1 medications like semaglutide, the active ...

Ozempic has been a breakthrough for many, correcting eating disorders and managing blood sugar, weight, and more. A recent New Yorker article highlights an under-discussed bio-psychological side ...

“The bottom line I would convey to patients is that tried and true lifestyle interventions — adequate protein, fiber, ...

Brianna believes Ozempic has a devastating side effect. The post Brianna Chickenfry Has Deadly Warning for Ozempic Users ...

Swedish people with depression and anxiety who took Novo Nordisk A/S’s blockbuster shots Ozempic and Wegovy were less likely ...

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...

Marsha Ettinghoff died from stomach paralysis, a condition where food passes through the stomach slower than it should.